The United States market for the insulin injection pen market is expected to touch US$ 5.5 billion by the year-end of 2027.
Report Scope:
• An Insightful Analysis of the United States Diabetes Population and Forecast to 2027
• Delivers a Complete Overview of the United States Insulin Users and Forecast to 2027
• The United States Insulin Injection Pen Market Size and Forecast (2015 – 2027)
• The United States Insulin Injection Pen Market Share & Y-o-Y Growth (%), 2015 – 2027
• The Market Size of the United States Smart Insulin Injection Pen Market with Six Years Forecast
• The Market Size of the United States Reusable Insulin Injection Pen Market with Six Years Forecast
• The Market Size of the United States Disposable Insulin Injection Pen with Six Years Forecast
• Detailed Assessment of the United States Smart Insulin Injection Pen Users Volume and Forecast to 2027
• Detailed Assessment of the United States Reusable Insulin Injection Pen Users Volume and Forecast to 2027
• Detailed Assessment of the United States Disposable Insulin Injection Pen Users Volume and Forecast to 2027
• Investigates the Key Growth Drivers and Restraints of the United States Insulin Injection Pen Market
• Detailed Insights into the Regulatory Framework of the United States Insulin Injection Pen Market
• Features Reimbursement Patterns of the United States Insulin Injection Pen Market
• A Comprehensive List of Key Market Players Along with the Analysis of their Current Insulin Injection Pen Portfolios, Business Overview, and Current Development
Market Segment by Type, the Product can be Split into
• Smart Insulin Injection Pen
• Reusable Insulin Injection Pen
• Disposable Insulin Injection Pen
The Major Companies Dominating this Market for their Products, Services, and Continuous Product Developments are:
• Novo Nordisk
• Eli Lilly
• Sanofi
• Owen Mumford
• Companion Medical
• Diabnext
• Digital Medics Ptd Ltd.
• Emperra GmbH E-Health Technologies
• Diamesco Co., Ltd.
Key Questions Addressed by the Report:
• How many people in the United States have diabetes?
• How many people in the United States use insulin?
• How has the United States insulin injection pen market performed so far?
• How is the United States insulin injection pen market anticipated to evolve during the forecast period 2021 – 2027?
• How is each segment of the United States insulin injection pen market expected to grow during the forecast period, and what is the revenue expected to be generated by each of the segments by the end of 2027?
• What are the main drivers and restraints in the United States insulin injection pen market?
• What are the various insulin injection pen devices available in the United States?
• What is the reimbursement scenario of the products offered in the United States insulin injection pen market?
• What is the regulatory system of the insulin injection pen market in the United States?
• Who are the top market players and what are their happenings, products, current developments, and scenarios?
'
1. Executive Summary
2. United States Diabetes Population and Forecast (2015 – 2027)
3. United States Insulin Users and Forecast (2015 – 2027)
4. United States Insulin Injection Pen Users, Market Size and Analysis (2015 – 2027)
4.1 Insulin Injection Pen Users and Forecast
4.2 Insulin Injection Pen Market and Forecast
5. United States Insulin Injection Pen Users, Market Share and Y–o–Y Growth (%), 2015 – 2027
5.1 Insulin Injection Pen Users Share and Forecast
5.2 Insulin Injection Pen Market Share and Forecast
6. United States Insulin Injection Pen Segmentation, By Product Type (2015 – 2027)
6.1 Reusable (Cartridge) Insulin Injection Pen Users and Market
6.1.1 Reusable (Cartridge) Insulin Injection Pen Users
6.1.2 Reusable (Cartridge) Insulin Injection Pen Market
6.2 Prefilled (Disposable) Insulin Injection Pen Users and Market
6.2.1 Prefilled (Disposable) Insulin Injection Pen Users
6.2.2 Prefilled (Disposable) Insulin Injection Pen Market
6.3 Smart Insulin Injection Pen Users and Market
6.3.1 Smart Insulin Injection Pen Users
6.3.2 Smart Insulin Injection Pen Market
7. Key Drivers and Inhibitors of the United States Insulin Injection Pen Market
7.1 Market Drivers
7.2 Market Inhibitors
8. United States Insulin Injection Pen Reimbursement Policies
9. United States Insulin Injection Pen Regulation System
10. Key Companies Analysis
10.1 Novo Nordisk
10.1.1 Business Overview
10.1.2 Insulin Injection Pen Products Offered
10.1.3 Recent Development
10.2 Eli Lilly
10.2.1 Business Overview
10.2.2 Insulin Injection Pen Products Offered
10.2.3 Recent Development
10.3 Sanofi
10.3.1 Business Overview
10.3.2 Insulin Injection Pen Products Offered
10.3.3 Recent Development
10.4 Owen Mumford
10.4.1 Business Overview
10.4.2 Insulin Injection Pen Products Offered
10.4.3 Recent Development
10.5 Companion Medical
10.5.1 Business Overview
10.5.2 Insulin Injection Pen Products Offered
10.5.3 Recent Development
10.6 Diabnext
10.6.1 Business Overview
10.6.2 Insulin Injection Pen Products Offered
10.6.3 Recent Development
10.7 Digital Medics Ptd Ltd.
10.7.1 Business Overview
10.7.2 Insulin Injection Pen Products Offered
10.7.3 Recent Development
10.8 Emperra GmbH E-Health Technologies
10.8.1 Business Overview
10.8.2 Insulin Injection Pen Products Offered
10.8.3 Recent Development
10.9 Diamesco Co., Ltd.
10.9.1 Business Overview
10.9.2 Insulin Injection Pen Products Offered
10.9.3 Recent Development
List of Tables:
Table 5–1: United States Insulin Injection Pen Users Share (Percent), 2015 – 2020
Table 5–2: United States Insulin Injection Pen Users Share Forecast (Percent), 2021 – 2027
Table 5–3: United States Insulin Injection Pen Market Share (Percent), 2015 – 2020
Table 5–4: United States Insulin Injection Pen Market Share Forecast (Percent), 2021 – 2027
Table 7–1: Worldwide Healthcare Spending on Diabetes (Billion US$), 2015 & 2040
List of Figures:
Figure 2–1: United States Diabetes Population (Thousand), 2015 – 2020
Figure 2–2: United States Diabetes Population Forecast (Thousand), 2021 – 2027
Figure 3–1: United States Insulin Users (Thousand), 2015 – 2020
Figure 3–2: United States Insulin Users Forecast (Thousand), 2021 – 2027
Figure 4–1: United States Insulin Injection Pen Users (Thousand), 2015 – 2020
Figure 4–2: United States Insulin Injection Pen Users Forecast (Thousand), 2021 – 2027
Figure 4–3: United States Insulin Injection Pen Market (Million US$), 2015 – 2020
Figure 4–4: United States Insulin Injection Pen Market Forecast (Million US$), 2021 – 2027
Figure 6–1: United States Reusable Insulin Injection Pen Users (Thousand), 2015 – 2020
Figure 6–2: United States Reusable Insulin Injection Pen Users Forecast (Thousand), 2021 – 2027
Figure 6–3: United States Reusable Insulin Injection Pen Market (Million US$), 2015 – 2020
Figure 6–4: United States Reusable Insulin Injection Pen Market Forecast (Million US$), 2021 – 2027
Figure 6–5: United States Prefilled Insulin Injection Pen Users (Thousand), 2015 – 2020
Figure 6–6: United States Prefilled Insulin Injection Pen Users Forecast (Thousand), 2021 – 2027
Figure 6–7: United States Prefilled Insulin Injection Pen Market (Million US$), 2015 – 2020
Figure 6–8: United States Prefilled Insulin Injection Pen Market Forecast (Million US$), 2021 – 2027
Figure 6–9: United States Smart Insulin Injection Pen Users and Forecast (Thousand), 2018 – 2027
Figure 6–10: United States Smart Insulin Injection Pen Market and Forecast (Million US$), 2018 – 2027
